This is a record

Captured February 27, 2018 11:06 pm

View Mode: Standard Screenshot
Title
Turing Pharmaceuticals explains why 5,000% price bump is necessary | Fortune
Description
Turing Pharmaceuticals and its CEO Martin Shkreli respond after the company boosted the price of Daraprim by over 5,000%.